Breaking AI & Tech News Analyzed

The increasing adoption of artificial intelligence (AI) in the workplace is having an unintended consequence: the creation of 'workslop'. Workslop refers to the flawed or inaccurate work generated by AI that needs to be heavily corrected, cleaned up, or completely redone. This phenomenon is causing frustration and decreased productivity among employees, who are often pressured by their employers to use AI to produce more work.Ken, a copywriter for a large cybersecurity firm, is one example of an employee struggling with workslop. After his company implemented AI chatbots, Ken found that the initial drafts were easy to create, but the rewriting and correction process was time-consuming and laborious. In fact, Ken and his coworkers had to spend more time rewriting and correcting errors than if they had never used AI at all.A recent survey of 5,000 white-collar US workers found a significant disconnect between employees and executives when it comes to AI. While 92% of high-level executives believe that AI makes them more productive, 40% of non-managers say that AI saves them no time at all. This disparity highlights the challenges of implementing AI in the workplace and the need for clearer mandates and use cases.The driving force behind workslop is complex and multifaceted. Companies have invested billions in enterprise AI, and some have laid off human workers, attributing the cuts to AI's potential productivity. However, workers who remain feel pressured to use AI to produce more work, often with little guidance or training. This has led to a situation where employees are outsourcing judgment to chatbots, with unclear consequences.Researchers have found that 40% of workers encounter workslop within a month, and spend an average of 3.4 hours a month dealing with it. This translates to significant lost productivity and costs for organizations. To address this issue, experts recommend that companies provide clearer mandates and use cases for AI, as well as more worker input and control over how the technology is used.

A recent study has confirmed what many people can already feel: summers are getting longer, and the trend is particularly pronounced in Sydney. The research, published in the journal Environmental Research Letters, found that summer conditions are arriving earlier, lasting longer, and feeling more intense due to human-induced global heating.The study, conducted by PhD candidate Ted Scott from the University of British Columbia, analyzed data from 10 global cities and found that the length of summer is increasing on average by six days every decade. However, in Sydney, Australia, the summer period is growing at a rate of about 15 days every decade.In Minneapolis, Minnesota, the summer length is increasing by nine days every decade, while Toronto in Canada is adding a little over eight days to its summer every decade. Paris and Reykjavik are adding 7.2 days to their summer periods.The research also found that the shift from one season to another is becoming more abrupt, with summer-like conditions arriving more suddenly rather than gradually warming up. Sydney's summer period has grown from 65 days in the 1960s to 125-130 days in recent years, with the summer starting almost a full month earlier on November 27 and ending on March 28.The study's findings have significant implications for various aspects of life, including school terms, sporting seasons, and crop planting. The researchers emphasize that the trend is driven by human-induced global heating and that reducing fossil fuel usage is crucial to mitigating the effects of climate change.

A remarkable fossil discovery in Victoria, Australia, has revealed that giant echidnas once roamed the region. The Owen's giant echidna, Megalibgwilia owenii, lived during the Pleistocene epoch, which began 2.5 million years ago.The fossil, discovered in the Buchan cave complex in East Gippsland, is a significant find, as it fills a 1,000km gap in the species' known distribution. Previously, specimens of the extinct monotreme had been found across Australia, from Western Australia to Tasmania, but mysteriously absent from the fossil record in Victoria.The Owen's giant echidna was about twice the size of Australia's modern echidnas, growing up to 1 metre long and weighing up to 15kg. Its skeleton is much more robust than that of comparably sized animals, with deeper, more prominent muscle scars and larger attachments for ligaments, indicating it was using much greater force when interacting with the landscape.According to Tim Ziegler, the collection manager of vertebrate palaeontology at the Museums Victoria Research Institute, the fossil was likely used for digging for buried larvae, larger prey of beetles, or bogong moths, or tearing tree bark to access food.The research, published in Alcheringa: An Australasian Journal of Palaeontology, provides new insights into the distribution and habitat of the Owen's giant echidna during the ice age.

The US political landscape is increasingly dominated by money, with billionaires and corporations spending vast amounts to influence elections and policy. In California, signature collectors are being paid $15 apiece to gather signatures in support of countermeasures against a proposed billionaire tax.The crisis has escalated since the 2010 Citizens United decision, which shredded limits on independent corporate election spending, fueling the growth of cash-flush Super Pacs and anonymous dark money non-profits. In 2024, $1.5bn in Super Pac donations came from organizations that aren’t required to name their donors.The ruling has, on balance, boosted conservatives, with Republicans receiving a four-point electoral bump in states where Citizens United struck down existing bans on corporate donations. Meanwhile, rampant income inequality has fueled a parallel democratic deficit, with the richest 10% of Americans now owning 93% of the stock market.To rebalance the scales, alternatives such as public election financing are being explored, which helped Zohran Mamdani secure his mayoral victory in New York City last year. Currently implemented in 15 states and Washington DC, these programs issue grants, vouchers and matching funds that augment the power of small donations.Citizens United might also be circumvented by novel legal maneuvering, with states holding considerable authority to define the powers they grant to incorporated entities. In Montana, organizers are collecting signatures for a Transparent Election Initiative that would strip corporations of the power to engage in election spending.

Lake Erie, a vital source of freshwater for millions of people, has faced significant pollution challenges for decades. In the 1960s, the lakes and rivers around Cleveland were so polluted that they frequently caught on fire. While water quality has improved since then, the lake still struggles with poor water quality due to chemical runoff and pollution. The 2025 State of the Great Lakes report found that Lake Erie ranks poorly for pollution caused by chemical runoff and is consistently one of the top five most polluted lakes in the US. Over 5.5 billion gallons of freshwater are drawn from the lake daily to meet industrial and consumer needs, highlighting the importance of addressing these pollution issues. In response, the Cleveland Water Alliance, a non-profit organization, is working with over 300 companies, research institutions, and government agencies to develop clean water solutions for Lake Erie. The alliance has deployed hundreds of sensor buoys across the western section of the lake to observe and detect various water-related factors, including E. coli, algal blooms, and turbidity levels. Researchers at Case Western Reserve University have incubated research for a pilot program technology that can capture 90% of microplastics down to 50 microns in washing machines, preventing these materials from entering the lake. Other projects are recording solar radiation, dissolved oxygen levels, and water and air temperatures. Korean companies have also come to the area to test electrochemical water treatment methods in Lake Erie's water. The alliance's efforts aim to position Lake Erie as an open-air research facility, driving innovation and solutions to address the lake's pollution challenges. Despite these efforts, environmentalists say the challenges to cleaning up the lake are huge. A 40% reduction in phosphorus is needed to minimize blooms, with about 90% of phosphorus entering the western Lake Erie basin coming from agricultural runoff. The manure problem is also a growing concern, with the increasing number of livestock operations in the area contributing to pollution. The Cleveland Water Alliance's initiatives, such as the development of a system for making commercial-grade sodium hypochlorite on site, aim to promote technologies for wintertime monitoring of aquatic life activity and behavioral changes as well as levels of water turbidity. By leveraging data and innovation, stakeholders hope to improve the lake's water quality and mitigate the impacts of pollution.

A comprehensive study from Denmark has concluded that taking acetaminophen, commonly known as Tylenol, during pregnancy has no effect on later autism diagnoses in children. The research, which utilized Denmark's robust national healthcare system to track more than 1.5 million children born between 1997 and 2022, including 31,098 children who were exposed to Tylenol in utero, found no significant link between Tylenol use and autism. The study's findings contradict claims made by the Trump administration, which had suggested that Tylenol use during pregnancy was a major cause of autism in children. This led to a notable 16% drop in Tylenol orders for pregnant women in emergency rooms following the announcement. However, the new study provides reassurance that Tylenol is safe to use during pregnancy for pain relief and fever reduction. According to the study, autism was diagnosed in 1.8% of children who were exposed to Tylenol and 3% of those who weren’t. A similar 2024 study in Sweden found a marginal link that disappeared after considering siblings, suggesting that autism is strongly genetic. Health officials had previously announced a label change for acetaminophen, warning of a potential link to autism, which has now been called into question. Experts, such as Jeremy Faust, an emergency physician at Mass General Brigham and a health services researcher at Harvard Medical School, have noted that the words of health officials can significantly affect behavior, as evidenced by the drop in Tylenol orders. However, Faust also emphasized that Tylenol remains one of the safest options for pain control and fever reduction during pregnancy.

The Department for Culture, Media and Sport, acting on Historic England’s advice, has awarded Grade II* listed status to a limestone rubble barn on a grassy knoll in the Lake District, joining an elite roster that includes Battersea Power Station and the London Coliseum.Dubbed “Henry’s Castle,” the structure was most recently used as a shelter for livestock, but research suggests it may date back to the 14th century and originally served a high‑status function that remains unknown.Only 5.8% of England’s listed buildings achieve the Grade II* level, indicating they possess “more than special interest.” The barn’s unusual features – a corbelled chimney stack, a stepped garderobe, and a plastered interior showing signs of fire – set it apart from ordinary field barns.Historic England’s listing team leader, Sarah Charlesworth, described the building as “one of those rare structures that raises more questions than it answers,” underscoring its intrigue for scholars and visitors alike.Lake District National Park’s built‑environment adviser, Rose Lord, recalled her 2022 visit, noting that despite layers of animal manure the barn’s architecture hinted at something “very special” – a construction far beyond typical agricultural outbuildings.Four years of meticulous work by archaeologists, architects, and conservation engineers have restored the barn’s most striking element: an oak roof featuring a hand‑finished, chamfered and pegged central truss, a technique associated with high‑quality carpentry of the 14th or 15th centuries.Experts speculate on the barn’s original purpose, ranging from a defensive lookout or hunting lodge to a luxurious summer house. Historic England notes similarities to bastles – fortified farmhouses common along the Anglo‑Scottish border – though the building’s location south of the border makes a strict classification unlikely.Originally converted to domestic use in the 16th or 17th century and later repurposed as a field barn by the 19th century, the structure takes its name from former owner farmer Henry Willison.Lord called the new listing the “cherry on the cake” for the restoration project, highlighting that most buildings of comparable significance have already been recorded in earlier surveys. Interpretation panels and an owl‑nesting box are slated for installation in the coming weeks, adding educational and ecological value to the site.

Recent CDC data reveal a dramatic 1,200% increase in kratom‑related poisonings across the United States over the last ten years, with the most pronounced surge recorded in 2025. Researchers link this rise to the growing presence of 7‑hydroxymitragynine (7‑OH), a synthetically produced compound that mimics kratom’s effects but carries opioid‑like risks. Walter Prozialeck, pharmacology professor at Midwestern University, said the trend was expected, noting that the synthetic alkaloid has entered the market through energy drinks and other products since 2024. Christopher McCurdy of the University of Florida warned that marketing 7‑OH as “enhanced kratom” blurs the line for consumers, turning poison‑control calls into a conflated metric for both natural and synthetic products. By contrast, natural kratom (Mitragyna speciosa)—a Southeast Asian plant used for centuries as a pain reliever—has demonstrated a relatively favorable safety profile in animal and human studies. A 2018 statement from then‑HHS Secretary Brett Giroir rejected the DEA’s push to schedule kratom as a Schedule I substance, citing insufficient evidence of harm. Despite the scientific distinction, several states have moved to implement or propose blanket bans on all kratom products, prompting concern from clinicians and patient advocates. A recent user survey indicated that about 50% of respondents rely on kratom for chronic pain, while roughly 40% use it during addiction recovery. Personal testimonies underscore the plant’s therapeutic role. Jeff Maslan, a 68‑year‑old Californian with severe osteoarthritis, credits kratom with easing opioid withdrawal after multiple surgeries. Similarly, “Steven,” a disabled California resident, describes how kratom eliminated unbearable oxycodone withdrawal symptoms without producing the euphoric “warm fuzzy” feeling typical of opioids. Researchers emphasize that 7‑OH carries genuine opioid hazards, including addiction, severe withdrawal, and respiratory depression that can lead to fatal overdose. In animal models, 7‑OH demonstrated the same respiratory‑depression risk as classic opioids, whereas kratom’s primary alkaloid did not. Prozialeck and colleagues explain that kratom’s pharmacology is more nuanced: it partially activates opioid receptors while also engaging adrenergic and serotonin pathways, resembling a hybrid of a weak opioid and an SNRI‑type antidepressant. This multimodal action likely accounts for its lower euphoric potential and the reported boost in energy among users. Nevertheless, experts caution that kratom is not without risk. Fatal poisonings often involve co‑ingestion of potent opioids such as fentanyl, suggesting that some users may cycle between kratom and stronger substances, raising overdose danger due to reduced opioid tolerance. Additionally, heavy‑metal contamination has been detected in certain kratom batches, though the source—soil, processing, or storage—remains unclear. Given these complexities, the consensus among scholars like Austin Zamarripa (Johns Hopkins) is that natural kratom should remain accessible, while concentrated 7‑OH products merit stricter regulation. “These products may offer meaningful benefits to some individuals, and those benefits could be lost if access is restricted too broadly,” Zamarripa said, urging a differentiated policy approach. As the debate unfolds, patients like Steven worry that a sweeping ban would ignore the nuanced safety profile of the plant. “There’s corn on the cob, there’s high‑fructose corn syrup, there’s whiskey— all derived from corn but fundamentally different,” he remarked, highlighting the need for targeted, evidence‑based regulation rather than a one‑size‑fits‑all prohibition.

Scientists at London's Institute of Cancer Research and the RCSI University of Medicine and Health Sciences in Dublin have announced a new AI-driven approach to identify how patients with advanced bowel cancer will respond to bevacizumab, a drug recently introduced by the NHS. The method uses PhenMap, an AI tool that integrates complex data on the genetic makeup of tumors, allowing researchers to track patterns of how different patients react to the drug. This development aims to spare potentially thousands of patients from being given drugs that would be ineffective in fighting their cancers. In the UK alone, nearly 10,000 cases of advanced bowel cancer are identified every year, with young adults seeing a particular rise in diagnoses. Bowel cancer has the second-highest mortality rate of any cancer, behind only lung cancer. While survival rates can be as high as 98% when caught early, the five-year survival rate for advanced bowel cancer can be as low as 10%. The study tracked 117 European bowel cancer patients who had been treated with chemotherapy and bevacizumab. Researchers identified a group of patients who all had the same gene mutation and were at a high risk of having negative reactions. The scientists behind the tests now hope to expand the number of patient samples and see if the results can be used in treatments for other types of cancer. Anguraj Sadanandam, a professor in stratification and precision medicine at the ICR, said: “Once bowel cancer spreads to other parts of the body, there are very few treatment options available for patients. It is therefore positive that patients can now access the targeted drug bevacizumab on the NHS. However, we know that the majority of patients won’t benefit from the drug, meaning thousands of people in England could be facing unpleasant side effects unnecessarily.” Sadanandam added that while the findings were encouraging, the tool would need to be tested on a larger cohort to be validated. “In future, I hope this approach will lead to a test that can be used by clinicians, to ensure patients receive personalised care that has the highest chance of working against their cancer.”